Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.k

Sarcoid-like granulomatosis (endo-/extrathoracic)

Publications

Chopra A, Nautiyal A, Kalkanis A, Judson MA

Drug-Induced Sarcoidosis-Like Reactions.

Chest. 2018;154(3):664-677

Wittram C, Mark EJ, McLoud TC

CT-histologic correlation of the ATS/ERS 2002 classification of idiopathic interstitial pneumonias.

Radiographics : a review publication of the Radiological Society of North America, Inc. 2003;23(5):1057-71

Haramati LB, Lee G, Singh A, Molina PL, White CS

Newly diagnosed pulmonary sarcoidosis in HIV-infected patients.

Radiology. 2001;218(1):242-6

Naccache JM, Antoine M, Wislez M, Fleury-Feith J, Oksenhendler E, Mayaud C, Cadranel J

Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

American journal of respiratory and critical care medicine. 1999;159(6):2009-13